Guzauskas, G. F., Basu, A., Serbin, M., Carlson, J. J., & Veenstra, D. L. (2019). Are there different evidence thresholds for genomic vs. clinical precision medicine? A VOI-based framework applied to antiplatelet drug therapy. Value Health.
Chicago-tyylinen lähdeviittausGuzauskas, Gregory F., Anirban Basu, Michael Serbin, Josh J. Carlson, ja David L. Veenstra. "Are There Different Evidence Thresholds for Genomic Vs. Clinical Precision Medicine? A VOI-based Framework Applied to Antiplatelet Drug Therapy." Value Health 2019.
MLA-viiteGuzauskas, Gregory F., et al. "Are There Different Evidence Thresholds for Genomic Vs. Clinical Precision Medicine? A VOI-based Framework Applied to Antiplatelet Drug Therapy." Value Health 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.